Holen Sie sich die Stockscreener-App
19.83
3.83%
-0.79
Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.74%
3.701
|
3.04 | 0.032 | 0.348 | 19.14 |
Operating Expenses
|
11.56%
68.56
|
61.46 | 66.01 | 55.49 | 54.78 |
| Depreciation and Amortization |
35.04%
0.089
|
0.137 | 0.133 | 0.125 | 0.107 |
| Operating Income/Loss |
11.03%
-64.86
|
-58.42 | -65.98 | -55.14 | -35.63 |
| Income/Loss From Continuing Operations Before Tax |
32.40%
-64.14
|
-48.44 | -74.92 | -72.00 | -17.36 |
| Net Income/Loss |
32.40%
-64.14
|
-48.44 | -74.92 | -72.00 | -17.36 |
| Basic Average Shares |
1.36%
123.37
|
121.72 | 0.5198 | 119.00 | 118.56 |
| Diluted Average Shares |
1.36%
123.37
|
121.72 | 0.5198 | 119.00 | 118.56 |
| Basic Earnings Per Share |
30.00%
-0.52
|
-0.40 | -0.63 | -0.61 | -0.15 |
| Diluted Earnings Per Share |
30.00%
-0.52
|
-0.40 | -0.63 | -0.61 | -0.15 |
2.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):